Submitted by Anonymous (not verified) on 16 June 2026 - 11:20
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 4, Status: Authorised